- Home
- INTS vs MASK Comparison
INTS vs MASK Comparison
Compare INTS & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- MASK
- Stock Information
- Founded
- INTS 2012
- MASK 2017
- Country
- INTS United States
- MASK Hong Kong
- Employees
- INTS N/A
- MASK N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- MASK
- Sector
- INTS Health Care
- MASK
- Exchange
- INTS Nasdaq
- MASK NYSE
- Market Cap
- INTS 7.4M
- MASK 27.7M
- IPO Year
- INTS 2023
- MASK 2025
- Fundamental
- Price
- INTS $0.33
- MASK $1.44
- Analyst Decision
- INTS Strong Buy
- MASK
- Analyst Count
- INTS 3
- MASK 0
- Target Price
- INTS $8.50
- MASK N/A
- AVG Volume (30 Days)
- INTS 3.7M
- MASK 110.8K
- Earning Date
- INTS 08-07-2025
- MASK 01-01-0001
- Dividend Yield
- INTS N/A
- MASK N/A
- EPS Growth
- INTS N/A
- MASK 12.16
- EPS
- INTS N/A
- MASK 0.19
- Revenue
- INTS N/A
- MASK $4,718,055.00
- Revenue This Year
- INTS N/A
- MASK N/A
- Revenue Next Year
- INTS N/A
- MASK N/A
- P/E Ratio
- INTS N/A
- MASK $8.95
- Revenue Growth
- INTS N/A
- MASK 7.89
- 52 Week Low
- INTS $0.26
- MASK $1.60
- 52 Week High
- INTS $5.10
- MASK $4.19
- Technical
- Relative Strength Index (RSI)
- INTS 41.29
- MASK N/A
- Support Level
- INTS $0.26
- MASK N/A
- Resistance Level
- INTS $0.32
- MASK N/A
- Average True Range (ATR)
- INTS 0.03
- MASK 0.00
- MACD
- INTS 0.02
- MASK 0.00
- Stochastic Oscillator
- INTS 62.56
- MASK 0.00
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.